Overall Winner: Qure.ai·70/ 100
Q
Qure.aiWinner
VS

Qure.ai vs SigTuple

In-depth comparison — valuation, funding, investors, founders & more

Winner
Q
Qure.ai

🇮🇳 India · Prashant Warier

Series DAI HealthcareEst. 2016

Valuation

$270M

Total Funding

$157M

70
Awaira Score70/100

250 employees

Full Qure.ai Profile →
S
SigTuple

🇮🇳 India · Rohit Kumar Pandey

Series BAI HealthcareEst. 2015

Valuation

N/A

Total Funding

$20M

60
Awaira Score60/100

100-500 employees

Full SigTuple Profile →
🔬

Analyst Summary

Generated from real data · No AI hallucinations

Both Qure.ai and SigTuple compete directly in the AI Healthcare space, making this a head-to-head matchup within the same market segment. Qure. SigTuple develops AI-powered automated pathology solutions that digitize and analyze microscopy slides for blood, urine, sputum, and semen samples, enabling high-throughput diagnostic testing without the constant presence of trained pathologists.

Qure.ai carries a known valuation of $270M, while SigTuple's valuation has not been publicly disclosed. On the funding side, Qure.ai has raised $157M in total — $137M more than SigTuple's $20M.

SigTuple has 1 year more market experience, having been founded in 2015 compared to Qure.ai's 2016 founding. In terms of growth stage, Qure.ai is at Series D while SigTuple is at Series B — a meaningful difference for investors evaluating risk and upside.

Both companies are headquartered in 🇮🇳 India, competing for the same regional talent and customer base. On Awaira's 0–100 composite score, Qure.ai leads with a score of 70, reflecting stronger overall fundamentals across valuation, funding, and growth signals.

Metrics Comparison

MetricQure.aiSigTuple
💰Valuation
$270M
N/A
📈Total Funding
$157MWINS
$20M
📅Founded
2016WINS
2015
🚀Stage
Series D
Series B
👥Employees
250
100-500
🌍Country
India
India
🏷️Category
AI Healthcare
AI Healthcare
Awaira Score
70WINS
60

Key Differences

📈

Funding gap: Qure.ai has raised $137M more ($157M vs $20M)

📅

Market experience: SigTuple has 1 year more (founded 2015 vs 2016)

🚀

Growth stage: Qure.ai is at Series D vs SigTuple at Series B

👥

Team size: Qure.ai has 250 employees vs SigTuple's 100-500

⚔️

Direct competitors: Both operate in the AI Healthcare market segment

Awaira Score: Qure.ai scores 70/100 vs SigTuple's 60/100

Which Should You Choose?

Use these signals to make the right call

Q

Choose Qure.ai if…

Top Pick
  • Higher Awaira Score — 70/100 vs 60/100
  • More established by valuation ($270M)
  • Stronger investor backing — raised $157M
  • Qure
S

Choose SigTuple if…

  • More market experience — founded in 2015
  • SigTuple develops AI-powered automated pathology solutions that digitize and analyze microscopy slides for blood, urine, sputum, and semen samples, enabling high-throughput diagnostic testing without the constant presence of trained pathologists

Funding History

Qure.ai raised $157M across 5 rounds. SigTuple raised $20M across 0 rounds.

Qure.ai

Series D

Jan 2021

$81M

Series C

Jan 2020

$50M

Series B

Jan 2018

$20M

Series A

Jan 2017

Lead: Accel Partners

$6M

Seed

Jan 2016

SigTuple

No public funding data available.

Investor Comparison

No shared investors detected between these two companies.

Unique to Qure.ai

Accel PartnersBessemer Venture PartnersGoogle

Users Also Compare

FAQ — Qure.ai vs SigTuple

Is Qure.ai bigger than SigTuple?
Qure.ai has a disclosed valuation of $270M, while SigTuple's valuation is not publicly available, making a direct size comparison difficult. Qure.ai employs 250 people.
Which company raised more funding — Qure.ai or SigTuple?
Qure.ai has raised more in total funding at $157M, compared to SigTuple's $20M — a gap of $137M. Combined, the two companies have completed 5 known funding rounds.
Which company has a higher Awaira Score?
Qure.ai holds the higher Awaira Score at 70/100, compared to SigTuple's 60/100. The Awaira Score is a composite metric factoring in valuation, funding, stage, team size, and market presence — a 10-point gap that reflects meaningful differences in scale or traction.
Who founded Qure.ai vs SigTuple?
Qure.ai was founded by Prashant Warier in 2016. SigTuple was founded by Rohit Kumar Pandey in 2015. Visit each company's profile on Awaira for a full founder biography.
What does Qure.ai do vs SigTuple?
Qure.ai: Qure.ai is an Indian artificial intelligence company founded in 2016 that develops machine learning solutions for diagnostic imaging in healthcare. The company specializes in computer-aided detection and diagnosis systems that analyze medical imaging data including chest X-rays, CT scans, and mammograms to identify abnormalities and assist radiologists in clinical decision-making. Its platform uses deep learning algorithms trained on large datasets to detect conditions such as tuberculosis, COVID-19, lung cancer, and other pathologies. Qure.ai's products are deployed across hospitals and diagnostic centers in India and internationally, serving both institutional healthcare providers and diagnostic chains. The company has secured $157 million in total funding and operates at Series D stage with a valuation of $300 million as of recent rounds. Its technology addresses the shortage of radiologists in developing markets while improving diagnostic accuracy and turnaround times. Qure.ai competes in the medical AI space alongside companies like IBM Watson Health, Zebra Medical Vision, and various regional diagnostic AI providers. The company has demonstrated strong traction in the Indian healthcare market and has expanded its reach to international markets. Its growth trajectory reflects increasing adoption of AI-assisted diagnostic solutions globally and the rising demand for scalable healthcare technologies in resource-constrained settings. Qure.ai focuses specifically on diagnostic imaging AI for markets with radiologist shortages, positioning it distinctly within underserved geographies. SigTuple: SigTuple develops AI-powered automated pathology solutions that digitize and analyze microscopy slides for blood, urine, sputum, and semen samples, enabling high-throughput diagnostic testing without the constant presence of trained pathologists. The company's AI-Minth platform uses robotic sample preparation, high-resolution imaging, and deep learning analysis to deliver diagnostic-grade results.\n\nThe company raised approximately $20M in Series B funding and has deployed its automated microscopy systems at diagnostic labs, hospitals, and blood banks across India, processing millions of diagnostic samples. SigTuple has received regulatory approvals for its diagnostic AI products and has established partnerships with major diagnostic laboratory chains.\n\nIndia faces a severe shortage of qualified pathologists relative to population, creating an acute need for AI-assisted diagnostic automation. SigTuple's approach of combining hardware, robotics, and AI in an integrated system addresses the complete diagnostic workflow rather than just the software layer, creating higher deployment barriers but also higher switching costs and stronger network effects from accumulated diagnostic data.
Which company was founded first?
SigTuple was founded first in 2015, giving it 1 year of additional market experience. Qure.ai was founded later in 2016. In AI, even a year or two of head start can translate into significantly more training data, customer relationships, and institutional knowledge.
Which company has more employees?
Qure.ai has approximately 250 employees, while SigTuple has approximately 100-500. A larger team often signals higher revenue or venture backing, but in AI, smaller teams are increasingly capable of building at scale.
Are Qure.ai and SigTuple competitors?
Yes, Qure.ai and SigTuple are direct competitors — both operate in the AI Healthcare space and likely target overlapping customer segments. This comparison is especially relevant for buyers evaluating both platforms.